Certara, Inc. reported $408M of revenue over the trailing twelve months, +3.8% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $408M (to Q2 2026). Net income: −$68M, trailing twelve months to Q2 2026. Free cash flow: $80M, trailing twelve months to Q2 2026. Operating margin: −0.14%, trailing twelve months to Q2 2026.

CERTCertara, Inc.

Healthcare

$8.64-33% 1Y

$8.64

$4.4852 weeks$13.00

CERT as reported

Certara, Inc. reported $408M of revenue over the trailing twelve months, +3.8% on the year before. 10 reported series are charted on this page, each one as filed.

$408M

Revenue, trailing twelve months · to Q2 2026 · +3.8% against the twelve months before

Net income: −$68M
Net income · −957% year on year · trailing twelve months to Q2 2026
Free cash flow: $80M
Free cash flow · −20% year on year · trailing twelve months to Q2 2026
Operating margin: −0.14%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for CERT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$408M	+3.8%	Q2 2026
Net income	−$68M	−957%	Q2 2026
EPS	−$0.45	−1000%	Q2 2026
Gross margin	62%	n/a	Q2 2026
Operating margin	−0.14%	n/a	Q2 2026
Net margin	−18%	n/a	Q2 2026
ROE	−1.9%	n/a	Q2 2026
ROA	−1.3%	n/a	Q2 2026
ROIC	0.84%	n/a	Q2 2026
Free cash flow	$80M	−20%	Q2 2026

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.